Abel Hall »

Kymera Therapeutics shares owned by Abel Hall

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Abel Hall

Quarter filed Position value Share count Share price at filing
2025-12-31 $454k 5.8k 77.81

More positions owned by Abel Hall

Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Abel Hall

Top funds holding Kymera Therapeutics

venBio Select Advisor
Baker Bros. Advisors
Vanguard Group
FMR
BVF
Wellington Management Company
BlackRock
Atlas Venture Life Science Advisors
Siren
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management
Ubs Global Asset Management Americas
Merck & Co

View all funds holding Kymera Therapeutics